• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

REV7 具有一个动态衔接区域,以适应小分子 GTP 酶 RAN/ IpaB 配体,其活性受到 RanGTP/GDP 开关的调节。

REV7 has a dynamic adaptor region to accommodate small GTPase RAN/ IpaB ligands, and its activity is regulated by the RanGTP/GDP switch.

机构信息

School of Life Sciences, Tianjin University, Tianjin 300072, China.

Department of Molecular Biology, Ariel University, Ariel 40700, Israel.

出版信息

J Biol Chem. 2019 Oct 25;294(43):15733-15742. doi: 10.1074/jbc.RA119.010123. Epub 2019 Sep 4.

DOI:10.1074/jbc.RA119.010123
PMID:31484720
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6816109/
Abstract

REV7, also termed mitotic arrest-deficient 2-like 2 (MAD2L2 or MAD2B), acts as an interaction module in a broad array of cellular pathways, including translesion DNA synthesis, cell cycle control, and nonhomologous end joining. Numerous REV7 binding partners have been identified, including the human small GTPase Ras-associated nuclear protein (RAN), which acts as a potential upstream regulator of REV7. Notably, the invasin IpaB hijacks REV7 to disrupt cell cycle control to prevent intestinal epithelial cell renewal and facilitate bacterial colonization. However, the structural details of the REV7-RAN and REV7-IpaB interactions are mostly unknown. Here, using fusion protein and rigid maltose-binding protein tagging strategies, we determined the crystal structures of these two complexes at 2.00-2.35 Å resolutions. The structures revealed that both RAN and IpaB fragments bind the "safety belt" region of REV7, inducing rearrangement of the C-terminal β-sheet region of REV7, conserved among REV7-related complexes. Of note, the REV7-binding motifs of RAN and IpaB each displayed some unique interactions with REV7 despite sharing consensus residues. Structural alignments revealed that REV7 has an adaptor region within the safety belt region that can rearrange secondary structures to fit a variety of different ligands. Our structural and biochemical results further indicated that REV7 preferentially binds GTP-bound RAN, implying that a GTP/GDP-bound transition of RAN may serve as the molecular switch that controls REV7's activity. These results provide insights into the regulatory mechanism of REV7 in cell cycle control, which may help with the development of small-molecule inhibitors that target REV7 activity.

摘要

REV7,也称为有丝分裂阻滞缺陷 2 样 2(MAD2L2 或 MAD2B),作为广泛的细胞途径中的相互作用模块,包括跨损伤 DNA 合成、细胞周期控制和非同源末端连接。已经鉴定出许多 REV7 结合伴侣,包括人类小 GTP 酶 Ras 相关核蛋白(RAN),它作为 REV7 的潜在上游调节剂。值得注意的是,侵袭素 IpaB 劫持 REV7 以破坏细胞周期控制,以防止肠上皮细胞更新并促进细菌定植。然而,REV7-RAN 和 REV7-IpaB 相互作用的结构细节在很大程度上尚不清楚。在这里,我们使用融合蛋白和刚性麦芽糖结合蛋白标记策略,以 2.00-2.35 Å 的分辨率确定了这两个复合物的晶体结构。这些结构表明,RAN 和 IpaB 片段都结合 REV7 的“安全带”区域,诱导 REV7 的 C 末端β-片层区域的重排,该区域在 REV7 相关复合物中保守。值得注意的是,尽管 RAN 和 IpaB 的 REV7 结合基序都与 REV7 具有一些独特的相互作用,但它们都共享保守残基。结构比对表明,REV7 在安全带区域内具有一个衔接区域,该区域可以重排二级结构以适应各种不同的配体。我们的结构和生化结果进一步表明,REV7 优先结合 GTP 结合的 RAN,这表明 RAN 的 GTP/GDP 结合转变可能作为控制 REV7 活性的分子开关。这些结果提供了对 REV7 在细胞周期控制中的调节机制的深入了解,这可能有助于开发针对 REV7 活性的小分子抑制剂。

相似文献

1
REV7 has a dynamic adaptor region to accommodate small GTPase RAN/ IpaB ligands, and its activity is regulated by the RanGTP/GDP switch.REV7 具有一个动态衔接区域,以适应小分子 GTP 酶 RAN/ IpaB 配体,其活性受到 RanGTP/GDP 开关的调节。
J Biol Chem. 2019 Oct 25;294(43):15733-15742. doi: 10.1074/jbc.RA119.010123. Epub 2019 Sep 4.
2
Structural basis for shieldin complex subunit 3-mediated recruitment of the checkpoint protein REV7 during DNA double-strand break repair.屏蔽复合物亚基 3 介导的检查点蛋白 REV7 在 DNA 双链断裂修复过程中的募集的结构基础。
J Biol Chem. 2020 Jan 3;295(1):250-262. doi: 10.1074/jbc.RA119.011464. Epub 2019 Dec 3.
3
Dynamic feature of mitotic arrest deficient 2-like protein 2 (MAD2L2) and structural basis for its interaction with chromosome alignment-maintaining phosphoprotein (CAMP).有丝分裂阻滞缺陷蛋白2样蛋白2(MAD2L2)的动态特征及其与染色体排列维持磷蛋白(CAMP)相互作用的结构基础
J Biol Chem. 2017 Oct 27;292(43):17658-17667. doi: 10.1074/jbc.M117.804237. Epub 2017 Sep 8.
4
The C-terminal extension of the small GTPase Ran is essential for defining the GDP-bound form.小GTP酶Ran的C末端延伸对于定义GDP结合形式至关重要。
J Mol Biol. 2002 Apr 26;318(2):583-93. doi: 10.1016/S0022-2836(02)00040-2.
5
A T42A Ran mutation: differential interactions with effectors and regulators, and defect in nuclear protein import.一种T42A Ran突变:与效应物和调节因子的差异相互作用以及核蛋白导入缺陷。
Mol Biol Cell. 1997 Dec;8(12):2591-604. doi: 10.1091/mbc.8.12.2591.
6
A bacterial effector targets Mad2L2, an APC inhibitor, to modulate host cell cycling.一种细菌效应蛋白靶向Mad2L2(一种后期促进复合体抑制剂)来调节宿主细胞周期。
Cell. 2007 Aug 24;130(4):611-23. doi: 10.1016/j.cell.2007.06.043.
7
The mitotic arrest deficient protein MAD2B interacts with the small GTPase RAN throughout the cell cycle.有丝分裂缺陷蛋白 MAD2B 在整个细胞周期中与小分子 GTP 酶 RAN 相互作用。
PLoS One. 2009 Sep 15;4(9):e7020. doi: 10.1371/journal.pone.0007020.
8
Crystal structure of human REV7 in complex with a human REV3 fragment and structural implication of the interaction between DNA polymerase zeta and REV1.人 REV7 与人类 REV3 片段复合物的晶体结构及 DNA 聚合酶 ζ 和 REV1 相互作用的结构意义。
J Biol Chem. 2010 Apr 16;285(16):12299-307. doi: 10.1074/jbc.M109.092403. Epub 2010 Feb 17.
9
Different structural and kinetic requirements for the interaction of Ran with the Ran-binding domains from RanBP2 and importin-beta.Ran与RanBP2和输入蛋白β的Ran结合结构域相互作用的不同结构和动力学要求。
Biochemistry. 2000 Sep 26;39(38):11629-39. doi: 10.1021/bi001010f.
10
Rev7/Mad2B plays a critical role in the assembly of a functional mitotic spindle.Rev7/Mad2B 在功能性有丝分裂纺锤体的组装中起关键作用。
Cell Cycle. 2015;14(24):3929-38. doi: 10.1080/15384101.2015.1120922.

引用本文的文献

1
REV7: a small but mighty regulator of genome maintenance and cancer development.REV7:基因组维持和癌症发展的一个虽小却强大的调节因子。
Front Oncol. 2025 Jan 7;14:1516165. doi: 10.3389/fonc.2024.1516165. eCollection 2024.
2
MAD2L2 Dimerization Is Not Essential for Mitotic Regulation.MAD2L2 二聚化对于有丝分裂调控并非必需。
Int J Mol Sci. 2024 Oct 25;25(21):11485. doi: 10.3390/ijms252111485.
3
Probing hot spots of protein-protein interactions mediated by the safety-belt region of REV7.探测 REV7 安全带区域介导的蛋白质-蛋白质相互作用热点。
Structure. 2024 Nov 7;32(11):2134-2146.e3. doi: 10.1016/j.str.2024.09.007. Epub 2024 Oct 3.
4
REV7 Monomer Is Unable to Participate in Double Strand Break Repair and Translesion Synthesis but Suppresses Mitotic Errors.REV7 单体无法参与双链断裂修复和跨损伤合成,但能抑制有丝分裂错误。
Int J Mol Sci. 2023 Oct 31;24(21):15799. doi: 10.3390/ijms242115799.
5
Functions and Regulation of Meiotic HORMA-Domain Proteins.减数分裂 HORMAD 域蛋白的功能与调控。
Genes (Basel). 2022 Apr 27;13(5):777. doi: 10.3390/genes13050777.
6
MAD2B promotes podocyte injury through regulating Numb-dependent Notch 1 pathway in diabetic nephropathy.MAD2B 通过调节 Notch1 通路促进糖尿病肾病足细胞损伤。
Int J Biol Sci. 2022 Feb 21;18(5):1896-1911. doi: 10.7150/ijbs.68977. eCollection 2022.
7
Disrupting the MAD2L2-Rev1 Complex Enhances Cell Death upon DNA Damage.破坏 MAD2L2-Rev1 复合物可增强 DNA 损伤时的细胞死亡。
Molecules. 2022 Jan 19;27(3):636. doi: 10.3390/molecules27030636.
8
MAD2L2 dimerization and TRIP13 control shieldin activity in DNA repair.MAD2L2 二聚化和 TRIP13 控制 DNA 修复中的屏蔽活性。
Nat Commun. 2021 Sep 14;12(1):5421. doi: 10.1038/s41467-021-25724-y.
9
Targeting protein-protein interactions in the DNA damage response pathways for cancer chemotherapy.针对癌症化疗中DNA损伤反应通路中的蛋白质-蛋白质相互作用
RSC Chem Biol. 2021 Jun 21;2(4):1167-1195. doi: 10.1039/d1cb00101a. eCollection 2021 Aug 5.
10
REV7: Jack of many trades.REV7:多面手。
Trends Cell Biol. 2021 Aug;31(8):686-701. doi: 10.1016/j.tcb.2021.04.002. Epub 2021 May 4.

本文引用的文献

1
A Small Molecule Targeting Mutagenic Translesion Synthesis Improves Chemotherapy.小分子靶向诱变跨损伤合成可改善化疗。
Cell. 2019 Jun 27;178(1):152-159.e11. doi: 10.1016/j.cell.2019.05.028. Epub 2019 Jun 6.
2
Structural Approach To Identify a Lead Scaffold That Targets the Translesion Synthesis Polymerase Rev1.结构方法鉴定靶向跨损伤合成聚合酶 Rev1 的先导支架。
J Chem Inf Model. 2018 Nov 26;58(11):2266-2277. doi: 10.1021/acs.jcim.8b00535. Epub 2018 Oct 19.
3
Rev7 dimerization is important for assembly and function of the Rev1/Polζ translesion synthesis complex.Rev7 二聚化对于 Rev1/Polζ 跨损伤合成复合物的组装和功能至关重要。
Proc Natl Acad Sci U S A. 2018 Aug 28;115(35):E8191-E8200. doi: 10.1073/pnas.1801149115. Epub 2018 Aug 15.
4
53BP1 cooperation with the REV7-shieldin complex underpins DNA structure-specific NHEJ.53BP1 与 REV7-shieldin 复合物的合作是 DNA 结构特异性 NHEJ 的基础。
Nature. 2018 Aug;560(7716):122-127. doi: 10.1038/s41586-018-0362-1. Epub 2018 Jul 25.
5
The shieldin complex mediates 53BP1-dependent DNA repair.屏蔽复合物介导 53BP1 依赖性 DNA 修复。
Nature. 2018 Aug;560(7716):117-121. doi: 10.1038/s41586-018-0340-7. Epub 2018 Jul 18.
6
53BP1-RIF1-shieldin counteracts DSB resection through CST- and Polα-dependent fill-in.53BP1-RIF1-shieldin 通过 CST 和 Polα 依赖性填补来阻止 DSB 切除。
Nature. 2018 Aug;560(7716):112-116. doi: 10.1038/s41586-018-0324-7. Epub 2018 Jul 18.
7
Dynamic feature of mitotic arrest deficient 2-like protein 2 (MAD2L2) and structural basis for its interaction with chromosome alignment-maintaining phosphoprotein (CAMP).有丝分裂阻滞缺陷蛋白2样蛋白2(MAD2L2)的动态特征及其与染色体排列维持磷蛋白(CAMP)相互作用的结构基础
J Biol Chem. 2017 Oct 27;292(43):17658-17667. doi: 10.1074/jbc.M117.804237. Epub 2017 Sep 8.
8
Potential Strategies to Target Protein-Protein Interactions in the DNA Damage Response and Repair Pathways.靶向 DNA 损伤反应和修复途径中蛋白质-蛋白质相互作用的潜在策略。
J Med Chem. 2017 Dec 28;60(24):9932-9959. doi: 10.1021/acs.jmedchem.7b00358. Epub 2017 Jul 12.
9
Targeting the Translesion Synthesis Pathway for the Development of Anti-Cancer Chemotherapeutics.靶向跨损伤合成途径以开发抗癌化疗药物。
J Med Chem. 2016 Oct 27;59(20):9321-9336. doi: 10.1021/acs.jmedchem.6b00596. Epub 2016 Jul 19.
10
The multifaceted roles of the HORMA domain in cellular signaling.霍马结构域在细胞信号传导中的多方面作用。
J Cell Biol. 2015 Nov 23;211(4):745-55. doi: 10.1083/jcb.201509076.